01 August 2014 : Last day for early registration
20 August 2014 : Abstract Submission Deadline
15-19 October 2014 : Date of congress
SCIENTIFIC
PROGRAM
V. INTERNATIONAL EURASIAN CONGRESS OF HEMATOLOGY
PROGRAM
15-19 OCTOBER 2014
|
15 October 2014 Wednesday |
|||
|
16:00-16:30 |
Opening Speech |
Dr. Suleyman Dincer |
|
|
Moderators: Dr. Birol Guvenc , Dr. Giuseppe Saglio |
|||
|
16:30-17:00 |
CML: How do We Have to Treat our CML Patients in the era of Genetic Imatinib? |
Dr. Hagop Kantarijan |
|
|
17:00-17:30 |
The Essential Management of AML |
Dr. Alan Burnett |
|
|
17:30-18:00 |
The Essential Management of Adult ALL |
Dr. Dieter Hoelzer |
|
|
18:00-18:30 |
Next Generation Micro-analysis and Diagnosis Using Computational Imaging, Crowd-sourcing and Gaming |
Dr. Aydogan Ozcan |
|
|
18:30-19:00 |
Radiation and Leukemias |
Dr. Robert Gale |
|
|
19:00-20:00 |
Welcome Cocktail |
||
|
16 October 2014 Thursday |
||||
|
Moderators: Dr. Serdar Bedii Omay, Dr. Duzgun Ozatli, Dr. Mustafa Solak How Should We Treat MDS? |
||||
|
09:00-09:30 |
Myelodysplastic Syndromes: Old and New Classifications and Prognostic Scores |
Dr. Peter Greenberg |
||
|
09:30-10:00 |
Molecular Alterations of MDS |
Dr. Giullermo Garcia Manero |
||
|
10:00-10:30 |
Standard Treatment of MDS Including Transplant |
Dr. Elias Jabbour |
||
|
10:30-10:45 |
Open Coffee Break: Discussion with the Speakers |
|||
|
Moderators: Dr. Salih Aksu, Dr. Cengiz Beyan, Dr. Oktay Bilgir How Should We Treat Hodgkin Lymphoma? |
||||
|
10:45-11:15 |
Diagnosis and Staging |
Dr. Evren Ozdemir |
||
|
11:15-11:45 |
First-line Therapy, Evaluation of Response and Second line Therapy |
Dr. Alessandro Levis |
||
|
11:45-12:45 |
Lunch Break |
|||
|
Moderators: Dr. Osman Ilhan, Dr. Vahap Okan Specific Lectures |
||||
|
12:45-13:15 |
ECP for Certain Transplant Rejection |
Dr. Claudia Del Fante |
||
|
13:15-13:45 |
Iron Metabolism: New Horizon |
Dr. Hanan Hamed |
||
|
13:45-14:15 |
Graft Engineering to Prevent Viral Infection |
Dr. Francesco Saglio |
||
|
Moderators: Dr. Filiz Vural, Dr. Tulin Tuglular Firatli The Future: New Targets for Therapy of Hematological Malignancies - 1 |
||||
|
14:15-14:45 |
New Targets in ALL |
Dr. Sabina Chiaretti |
||
|
14:45-15:15 |
New Targets in AML: Only for Minimal Residual Disease? |
Dr. Mehmet Yilmaz |
||
|
15:15-15:45 |
Products situation of the Biosimilar in Turkey and in the world |
Dr. Alper İskit |
||
|
15:45-16:00 |
Open Coffee Break: Discussion with the Speakers |
|||
|
Moderators: Dr. Sehmuz Ertop, Dr. Hakan Goker, Dr. Mehmet Turgut The Future: New Targets for Therapy of Hematological Malignancies - 2 |
||||
|
16:00-16:30 |
New Targets in MPNs |
Dr. Tariq Mughal |
||
|
16:30-17:00 |
New Indications for Old Antibodies: HUS / PNH : A Model Disease |
Dr. Igor Lisukov |
||
|
Moderators: Dr. Aysen Timuragaoglu, Dr. Nilgun Sayinalp Infections in Hematology |
||||
|
17:00-17:30 |
IFI Management: Putting Theory into Practice |
Dr. Samir Agrawal |
||
|
17:30-18:00 |
New Antibiotic Strategy in Neutropenia |
Dr. Omrum Uzun |
||
|
18:00-18:30 |
Profilactic Anti Fungal Treatment in Hematologic Malignancies |
Dr. Esin Senol |
||
|
17 October 2014 Friday |
|||||
|
Moderators: Dr. Orhan Ayyildiz, Dr. Oral Nevruz, Dr. Ahmet İfran How to Manage Chronic Lymphoid Leukemias |
|||||
|
09:00-09:30 |
Current and evolving therapy of CLL |
Dr. Susan O’ Brien |
|||
|
09:30-10:00 |
Chimeric Antigen Receptor T Cells for Treatment of CLL |
Dr. J. Joseph Melenhorst |
|||
|
10:00-10:15 |
Open Coffee and Discussion with the Speakers |
||||
|
Moderators: Dr. Selim Yavuz, Dr. Guray Saydam How to manage Chronic Myeloid Leukemias and MPNs |
|||||
|
10:15-10:45 |
CML response monitoring in 2014 |
Dr. Naeem Chaudrhi |
|||
|
10:45-11:15 |
How I Treat Essential Thrombocythemia |
Dr. Jiri Schwarz |
|||
|
11:15-11:45 |
How I Manage PV |
Dr. Petro Petrides |
|||
|
11:45-12:45 |
Lunch Break |
||||
|
Moderators: Dr. Saidjalal Bakhramov,Dr. Rauf Haznedar, Dr. Levent Undar How to Treat Multiple Myeloma |
|||||
|
12:45-13:15 |
Which is Best and Most Convenient Treatment of Relapsed and Refractory Cases in Multiple Myeloma |
Dr. Michel Delforge |
|||
|
13:15-13:45 |
New Drugs in Multiple Myeloma |
Dr. Rafat Abanour |
|||
|
13:45-14:15 |
Optimizing Treatment of Multiple Myeloma Complications |
Dr. Evangelos Terpos |
|||
|
14:15-14:45 |
MRD Monitoring in Multiple Myeloma: Where are We Now? |
Dr. Bruno Paiva |
|||
|
14:45-15:00 |
Open Coffee Break and Discussion with Speakers |
|
|||
|
Moderator: Dr. Turker Cetin , Dr. Ali Kosar, Dr. İsmail Sari Specific Lectures |
|||||
|
15:00-15:30 |
Diagnosis and Management of Peri-Operative Risk (Bleeding and Trombozis) |
Dr. Burak Uz |
|||
|
15:30-16:00 |
Discussing IFI management with the guideline in FEN patients |
Dr. Livio Pagano |
|||
|
16:00-16:30 |
How to Manage Aplastic Anemia Without SCT |
Dr. Ali Unal |
|||
|
16:30-17:00 |
Rational Drug Use and Pharmaceutical Industry |
Sezen Tugba Koc |
|||
|
18 October 2014 Saturday |
||||
|
Moderators: Dr. Suleyman Dincer, Dr. Deniz Sargin, Dr. Yener Koc Stem Cell Transplant - 1 |
||||
|
09:00-09:30 |
CAR T-Cell Therapy |
Dr. Hanan Hamed |
||
|
09:30-10:00 |
Transplant in Thalassemia: an Update |
Dr. Federica Pilo |
||
|
10:00-10:30 |
What is Essential to know About Stem Cells |
Dr. Albert Donnenberg |
||
|
10:30-10:45 |
Open Coffee and Discussion with the Speakers |
|
||
|
Moderator: Dr. Mustafa Cetin, Dr. Mehmet Dagli, Dr. Hakan Akbulut Non-Hodgkin Lymphoma |
||||
|
10:45-11:15 |
How I Manage Indolent Non-Hogkin Lymphoma |
Dr. Berksoy Sahin |
||
|
11:15-11:45 |
How I manage Mantle Cell Lymphoma |
Dr. Carmino De Souza |
||
|
11:45-12:15 |
How I manage DLBCLs cell Lymphoma |
Dr. Khaled Halahleh |
||
|
12:15-13:30 |
Lunch Break |
|||
|
Moderators: Dr. Gulyuz Ozturk, Dr. Sevgi Kalayoglu Besisik, Dr. Bulent Eser, Stem Cell Transplant – 2 |
||||
|
13:30-14:00 |
Haploidentical Stem Cell Transplant |
Dr. Arnon Nagler |
||
|
14:00-14:30 |
Advances in Mobilization Failure |
Dr. Nabih Azar |
||
|
14:30-15:00 |
Cord Blood Transplant: A Reliable Alternative for Elderly Patients? |
Dr. Daniela Cilloni |
||
|
Closing Ceremony Prof. Giuseppe Saglio, Prof. Suleyman Dinçer, Prof. Birol Guvenc |
||||
|
16 October 2014 Thursday Pediatri Session |
|||
|
Moderators: Dr. Cengiz Asadov, Dr. Sabri Kemahli, Dr.Nejat Akar How I Manage Hemoglobinopathies |
|||
|
09:00-09:30 |
How I Manage Non Transfusion Dependent Thalassemia |
Dr. Bulent Antmen |
|
|
09:30-10:00 |
Management of Sickle Cell Disease |
Dr. Birol Guvenc |
|
|
10:00-10:15 |
When to Consider AlloSCT in Sickle Cell Disease? |
Dr. Salam Al-Kindi |
|
|
10:15-10:45 |
How I Manage Iron Overload |
Dr. Antonio Piga |
|
|
10:45-11:00 |
Coffee Break & Discussion With the Speakers |
||
|
Moderators: Dr. Sema Anak, Dr. Ahmet Faik Oner, Dr. Atilla Tanyeli Pediatric Onco-Hematology |
|||
|
11:00-11:30 |
SCTransplant in Children |
Dr. Francesco Frassoni |
|
|
11:30-12:00 |
Pediatric AML |
Dr. Burak Gumuscu |
|
|
12:00-12:30 |
Pediatric ALL |
Dr. Sema Anak |
|
|
12:30-13:30 |
Lunch Break |
||
|
Moderators: Dr. Turkiz Gursel, Dr. Kaan Kavakli Congenıtal Bleedıng Dısorders |
|||
|
13:30-14:00 |
The Safety of Products in Hemophilia Treatment |
Dr. Giovanni Di Minno |
|
|
14:00-14:30 |
Rare Bleeding Disorders |
Dr. Roula Farah |
|
|
14:30-15:00 |
Future of Hemophilia Care |
Dr. Prasad Mathew |
|
|
15:00-15:30 |
Advances in Clotting Factors: From Bench to Bedside |
Dr. Bulent Antmen |
|
* It will be described after formal response
16 October 2014 Thursday |
||
Dr. Nikolai Tupitsyn, Dr. Oktay Farajev |
||
16:00-16:30 |
PNH: A multisystemic and multidisciplinary disease |
Dr. Fahri Sahin |
16:30-17:00 |
Epigenetic Therapy for Treatment Pediatric Acute Myeloid Leukemia |
Dr. Valentina S.Nemirovchenko |
17:00-17:30 |
Mechanisms of haematopoietic stem cell mobilization in Hodgkin’s lymphoma patients |
Dr. Galina D. Petrova |
17:30-17:45 |
BEACOPP Regimen's Effectiveness in Recurrent and Refractory Hodgkin Lymphoma Types |
Dr. Rayimkul Karakulov |
17:45-18:00 |
Results of Autologous Peripheral Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma Without Maintenance Therapy |
Dr. Sherbet jusupova |
18:00-18:30 |
Thalassemia Intermedia Management |
Dr. Zohra Alimirzayeva |
